Impact BioMedical, INC. (IBO) Return on equity 2022–2025
Impact BioMedical, INC. (IBO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-96.2%FY2025 · since FY2022: -24.5% → -96.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -96.2% | — |
| FY2022 | -24.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice